- Home
- PMM vs RXST Comparison
PMM vs RXST Comparison
Compare PMM & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PMM | RXST |
|---|---|---|
| Founded | 1989 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.4M | 300.5M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | PMM | RXST |
|---|---|---|
| Price | $6.35 | $4.64 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $9.78 |
| AVG Volume (30 Days) | 86.8K | ★ 908.8K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 4.68% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | N/A | ★ $134,479,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.06 |
| P/E Ratio | $27.65 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.77 | $4.48 |
| 52 Week High | $6.52 | $13.65 |
Technical Indicators
Market Signals| Indicator | PMM | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 66.57 | 35.69 |
| Support Level | $6.06 | $4.48 |
| Resistance Level | $6.40 | $7.60 |
| Average True Range (ATR) | 0.05 | 0.29 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 100.00 | 23.94 |
Price Performance
Historical ComparisonAbout PMM Putnam Managed Municipal Income Trust
Putnam Managed Municipal Income Trust is a closed-end management investment company. Its investment objective is to seek a high level of current income exempt from federal income tax by investing in a diversified portfolio of tax-exempt municipal securities. The Fund invests in various sectors such as healthcare, retirement community, private higher education, housing-backed, essential service utilities, and state-backed bonds.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.